MX2018001815A - Vacunas de herpesvirus de pavo recombiante y uso de las mismas. - Google Patents
Vacunas de herpesvirus de pavo recombiante y uso de las mismas.Info
- Publication number
- MX2018001815A MX2018001815A MX2018001815A MX2018001815A MX2018001815A MX 2018001815 A MX2018001815 A MX 2018001815A MX 2018001815 A MX2018001815 A MX 2018001815A MX 2018001815 A MX2018001815 A MX 2018001815A MX 2018001815 A MX2018001815 A MX 2018001815A
- Authority
- MX
- Mexico
- Prior art keywords
- disease
- turkey herpesvirus
- recombinant turkey
- herpesvirus vaccines
- marek
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16341—Use of virus, viral particle or viral elements as a vector
- C12N2710/16343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16371—Demonstrated in vivo effect
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10071—Demonstrated in vivo effect
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La presente descripción proporciona un vector viral recombinante que comprende por lo menos un transgén insertado en un genoma viral de la enfermedad de Marek para tratamiento de enfermedades de aves de corral; también se proporcionan composiciones inmunogénicas que comprenden dichos vectores virales recombinantes y métodos para prevenir o inhibir la enfermedad de Marek en combinación con por lo menos una segunda enfermedad de aves de corral.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562203305P | 2015-08-10 | 2015-08-10 | |
PCT/US2016/045577 WO2017027324A1 (en) | 2015-08-10 | 2016-08-04 | Recombinant turkey herpesvirus vaccines and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2018001815A true MX2018001815A (es) | 2018-09-06 |
Family
ID=57984465
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018001815A MX2018001815A (es) | 2015-08-10 | 2016-08-04 | Vacunas de herpesvirus de pavo recombiante y uso de las mismas. |
MX2022006602A MX2022006602A (es) | 2015-08-10 | 2018-02-12 | Vacunas de herpesvirus de pavo recombinante y uso de las mismas. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2022006602A MX2022006602A (es) | 2015-08-10 | 2018-02-12 | Vacunas de herpesvirus de pavo recombinante y uso de las mismas. |
Country Status (6)
Country | Link |
---|---|
US (3) | US10537628B2 (es) |
EP (1) | EP3334833A4 (es) |
BR (1) | BR112018002887A2 (es) |
HK (1) | HK1257191A1 (es) |
MX (2) | MX2018001815A (es) |
WO (1) | WO2017027324A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3334833A4 (en) * | 2015-08-10 | 2019-04-24 | The Texas A&M University System | RECOMBINANT TURKEY HERPES VIRUS VACCINES AND USES THEREOF |
DK3471766T5 (da) | 2016-06-17 | 2023-05-08 | Intervet Int Bv | Rekombinante, ikke-patogene mareks sygdomsviruskonstrukter, der koder for infektiøs laryngotracheitisvirus-og infektiøs bursitis virus-antigener |
EP3391903B1 (en) | 2017-04-21 | 2022-02-23 | The Pirbright Institute | Recombinant gallid herpesvirus 3 vaccines encoding heterologous avian pathogen antigens |
CN108543067A (zh) * | 2017-12-25 | 2018-09-18 | 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) | 共表达h5亚型禽流感ha蛋白和传染性法氏囊vp2蛋白的重组火鸡疱疹病毒疫苗株 |
CN108841996A (zh) * | 2018-04-19 | 2018-11-20 | 华南农业大学 | 新城疫新型可视化重组酶聚合酶常温扩增核酸试纸条检测试剂盒及应用 |
CN111471701B (zh) * | 2020-04-27 | 2021-12-10 | 浙江鼎持生物制品有限公司 | 高效表达鹅星状病毒可溶性衣壳蛋白的orf2基因的方法及其应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2728795B1 (fr) | 1994-12-30 | 1997-03-21 | Rhone Merieux | Vaccin vivant recombinant aviaire, utilisant comme vecteur un virus herpes aviaire |
UA92913C2 (ru) | 2005-06-20 | 2010-12-27 | Кадила Хелткере Лимитед | Экспрессионный вектор и способы продуцирования высоких уровней белков |
ES2635019T3 (es) * | 2010-10-18 | 2017-10-02 | Intervet International B.V. | Vacuna con vector del herpesvirus de pavo contra la gripe aviar en aves de corral |
MX352206B (es) | 2011-10-21 | 2017-11-13 | Intervet Int Bv | Contrucciones no patogenicas recombinantes del virus de la enfermedad de marek que codifican para antigenos del virus de la laringotraqueitis infecciosa y del virus de la enfermedad de newcastle. |
CN104159605B (zh) * | 2011-11-30 | 2019-04-19 | 梅里亚有限公司 | 表达禽类病原体的抗原的重组禽疱疹病毒3型(mdv血清型2型)载体及其用途 |
CN103589693B (zh) | 2013-11-13 | 2016-02-03 | 江苏省农业科学院 | 一种表达ibdv vp2和法氏囊素三肽嵌合蛋白重组火鸡疱疹病毒 |
EP3334833A4 (en) * | 2015-08-10 | 2019-04-24 | The Texas A&M University System | RECOMBINANT TURKEY HERPES VIRUS VACCINES AND USES THEREOF |
-
2016
- 2016-08-04 EP EP16835663.2A patent/EP3334833A4/en active Pending
- 2016-08-04 US US15/228,912 patent/US10537628B2/en active Active
- 2016-08-04 BR BR112018002887A patent/BR112018002887A2/pt active IP Right Grant
- 2016-08-04 MX MX2018001815A patent/MX2018001815A/es unknown
- 2016-08-04 WO PCT/US2016/045577 patent/WO2017027324A1/en active Application Filing
-
2018
- 2018-02-12 MX MX2022006602A patent/MX2022006602A/es unknown
- 2018-12-18 HK HK18116168.2A patent/HK1257191A1/zh unknown
-
2019
- 2019-11-26 US US16/696,943 patent/US10813991B2/en active Active
-
2020
- 2020-10-14 US US17/070,664 patent/US11433130B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP3334833A4 (en) | 2019-04-24 |
US20210093710A1 (en) | 2021-04-01 |
EP3334833A1 (en) | 2018-06-20 |
BR112018002887A2 (pt) | 2018-11-06 |
WO2017027324A1 (en) | 2017-02-16 |
US20200147200A1 (en) | 2020-05-14 |
HK1257191A1 (zh) | 2019-10-18 |
US11433130B2 (en) | 2022-09-06 |
MX2022006602A (es) | 2022-07-11 |
US20170043006A1 (en) | 2017-02-16 |
US10813991B2 (en) | 2020-10-27 |
US10537628B2 (en) | 2020-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2022006602A (es) | Vacunas de herpesvirus de pavo recombinante y uso de las mismas. | |
MX2022005291A (es) | Vacunas para el tratamiento y prevencion del cancer. | |
MX2018014573A (es) | Vacuna contra el virus del zika. | |
PH12017500216B1 (en) | Vaccine in serotype-9 fowl adenovirus recombinant vector | |
PH12020500080A1 (en) | Senecavirus a immunogenic compositions and methods thereof | |
HUE048551T2 (hu) | Nukleinsav-szerkezetek és génterápiás vektorok Wilson-kór és egyéb állapotok kezelésében történõ alkalmazásra | |
MX2017008504A (es) | Vacuna para enfermedad de newcastle y de bursitis infecciosa (nd-ibd) en vector de hvt mejorada. | |
WO2015134368A3 (en) | Recombinant herpes simplex virus 2 (hsv-2) vaccine vectors | |
EP3579869A4 (en) | LIVE ATTENUATED CIKAVIRUS WITH 3'-UTR DELETION, VACCINE WITH IT AND USE OF IT | |
PH12018501154A1 (en) | Attenuated infectious bronchitis virus | |
MX2018000353A (es) | Sistema vector de adenovirus aviar 9 (fadv-9) y metodos asociados. | |
MX2022002994A (es) | Vectores de herpesvirus de los pavos recombinante que expresan antígenos de patógenos aviares y usos de estos. | |
PH12017501165A1 (en) | Dengue virus vaccine compositions and methods of use thereof | |
IL254698A0 (en) | A vaccine based on the recombinant Jarl Lin mumps virus 2 | |
MX363264B (es) | Vectores de vacuna recombinante de herpesvirus bovino 1 (bohv-1) con baja virulencia. | |
CA3045626A1 (en) | Bovine herpesvirus type 1 (bohv-1) vector against bovine respiratory disease complex | |
TN2014000393A1 (en) | Modified marek's disease virus, and vaccines made therefrom | |
NZ618125A (en) | Genetic vaccines against hendra virus and nipah virus | |
AU2019268149A1 (en) | Live attenuated heterologous vaccine for Leptospira | |
MX2019006245A (es) | Construcciones de vectores virales para la expresion de adyuvantes geneticos que activan las rutas cd40 y sting. | |
MX2015011064A (es) | Vacuna contra el virus de la leucemia bovina. | |
MX2016003470A (es) | Identificacion de proteinas inmunogenicas para el control de ectoparasitos. | |
MX2018013358A (es) | Vacunas para el virus del papiloma humano y metodos para su uso. |